Table 1

STS clinical and non-clinical risk factors by sex

SexInteraction with sex
CharacteristicMale (n=9818, 73.7%)Female (n=3509, 26.3%)p Value*p Value†
Demographics
 Age‡64.0±10.265.9±10.9<0.0030.889
 Body surface area‡ (m2)2.1±0.21.8±0.2<0.0030.793
 Race<0.0030.797
  White79.5%74.5%
  Black5.8%11.7%
  Hispanic9.0%8.9%
  Other/unknown5.7%4.9%
Risk factors
 Diabetes mellitus41.1%50.0%<0.0030.950
 Renal failure (dialysis)2.5%3.4%0.1080.829
 Creatinine‡ (mg/dL)1.3±1.01.2±1.1<0.0030.887
 Chronic lung disease13.7%18.3%<0.0030.316
 Hypertension85.5%89.6%<0.0030.739
 Cerebrovascular disease11.7%18.4%<0.0030.173
 Time from last MI to surgery0.0620.327
  None50.9%54.4%
  ≤6 h1.3%1.5%
  >6 and <24 h2.6%2.5%
  ≥24 h45.2%41.7%
 Tobacco use>0.990.806
  Never72.7%73.7%
  Previous21.1%20.4%
  Current6.2%6.0%
Previous interventions
 Previous PCI30.3%27.9%0.1500.481
 Previous CABG4.5%3.8%>0.990.310
Preoperative cardiac status
 Preoperative angina (w/in 2 weeks)24.4%24.1%>0.990.882
 Preoperative atrial fibrillation (29% missing)9.4%8.4%>0.990.962
Haemodynamics and catheterisation
 Ejection fraction‡ (7% missing)49.6%±13.4%53.1%±13.0%<0.0030.680
 Left main disease32.5%32.3%>0.990.119
Operative
 Status0.0420.885
  Elective50.4%47.3%
  Non-elective49.7%52.7%
 Bypass use§<0.003
  Off-pump CABG39.5%43.8%NA§
  On-pump CABG60.6%56.2%
 Preoperative IABP10.9%10.6%>0.990.004
Male OR (95% CI) =3.8 (2.7,5.2)
Female OR (95% CI) =6.5 (4.4,9.6)
Unadjusted short-term mortality2.10%3.90%<0.0001NA
  • *p Values using Pearson χ2 and Bonferroni correction.

  • †p Values using Wald χ2.

  • ‡Mean±SD with Wilcoxon signed sum-rank test for p value.

  • §Not included in the STS risk score; nor in our propensity-adjusted analysis.

  • CABG, coronary artery bypass graft; CI, confidence interval; IABP, intra-aortic balloon pump; MI, myocardial infarction; NA, not available; OR, odds ratio; PCI, percutaneous coronary intervention; STS, Society of Thoracic Surgeons.